New Frontiers in Treatment for Gynecologic Cancers
A special issue of Current Oncology (ISSN 1718-7729). This special issue belongs to the section "Gynecologic Oncology".
Deadline for manuscript submissions: closed (14 February 2022) | Viewed by 64678
Special Issue Editors
Interests: gynecologic cancers or precancerous; health services research; evidence based medicine
Special Issue Information
Dear Colleagues,
For the longest time, the management of gynecologic malignancies was very streamlined, with few options and mediocre outcomes, especially for those with advanced or recurrent disease. In the recent past, however, there has been a rapid advancement in care, including methods of surgical access to the malignancy, molecular diagnosis, and classification of disease, personal medicine therapeutic options and methods of radiation therapy, and combinations thereof. We invite researchers to address one of these topics related to malignancies of the ovary/fallopian tube, uterus, cervix/vagina/vulvar (lower genital tract), or gestational trophoblastic neoplasm.
Dr. Laurie M. Elit
Dr. Taymaa May
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- gynecologic cancers (ovary/fallopian tube, uterus, cervix, vagina, vulva, GTN)
- immune inhibitors
- PARP inhibitors
- ERAS
- minimally invasive surgery
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.